Dark
Streaming/Mobile
Old Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
03:12:34 EDT Mon 06 May 2024
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
News for U:BSEM from 2023-05-07 to 2024-05-06 - 24 items
News Releases
In The News
Other
CA
US
Date
Sym
Price
Type
Headline
2024-04-30 08:30
U
U:BSEM
News Release
200
BioStem Technologies Retains Clinical Research Industry Veteran Nick McCoy to Lead DFU and VLU trials for BioREtain Allografts
2024-04-25 08:00
U
U:BSEM
News Release
200
BioStem Technologies to Present at the 2024 Planet MicroCap Showcase
2024-04-24 08:00
U
U:BSEM
News Release
200
BioStem Technologies Inc. Completes Two-Year Audit, Prepares for Uplisting to Senior Exchange
2024-04-02 08:00
U
U:BSEM
News Release
200
BioStem Technologies to Present at the 14th Annual LD Micro Invitational Conference
2024-04-01 16:05
U
U:BSEM
News Release
200
BioStem Technologies Reports Fourth Quarter Revenue of $11.5 Million, 14-Fold YoY Increase
2024-03-21 08:00
U
U:BSEM
News Release
200
BioStem Technologies to Report Fourth Quarter 2023 Financial Results on Monday, April 01, 2024
2024-02-26 10:39
U
U:BSEM
News Release
200
PRISM MarketView Spotlights BioStem Technologies in the Expanding Wound Care Market
2024-01-30 16:05
U
U:BSEM
News Release
200
Amniowrap2 ¢ „ ¢ Product Launch Leads Year of Highlights for BioStem Technologies
2024-01-11 08:30
U
U:BSEM
News Release
200
BioStem Technologies Appoints Proven Life Science Sales Leader Shawn McCarrey to Chief Commercial Officer Role
2023-12-19 08:30
U
U:BSEM
News Release
200
BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors
2023-12-14 08:30
U
U:BSEM
News Release
200
Center for Medicare Services Established National Pricing of AmnioWrap2 ¢ „ ¢ ‚ in All MAC Regions
2023-12-13 08:30
U
U:BSEM
News Release
200
BioStem Technologies Bolsters Leadership with Appointment of Thomas Dugan to Board of Directors
2023-11-13 17:18
U
U:BSEM
News Release
200
BioStem Technologies Reports Third Quarter 2023 Operating and Financial Results
2023-11-08 08:31
U
U:BSEM
News Release
200
BioStem Technologies Awarded Q Code for VENDAJE AC ‚ ® Line from Centers for Medicare and Medicaid Services
2023-11-06 08:32
U
U:BSEM
News Release
200
BioStem Technologies to Report Third Quarter 2023 Financial Results on Tuesday, November 14, 2023
2023-11-03 08:30
U
U:BSEM
News Release
200
BioStem Technologies Closes Oversubscribed $2M Private Placement
2023-10-24 08:33
U
U:BSEM
News Release
200
BioStem Technologies Announces Opening of First Clinical Site for Diabetic Foot Ulcer Study
2023-10-17 12:11
U
U:BSEM
News Release
200
BioStem Technologies to Highlight Core Advanced Wound Care Portfolio at SAWC Fall 2023 Conference
2023-09-29 08:32
U
U:BSEM
News Release
200
BioStem Technologies: CMS Decision a ¢ € œWin For Patients ¢ €
2023-09-26 08:34
U
U:BSEM
News Release
200
BioStem Receives IRB Approval for Clinical Study to Evaluate Vendaje(R) in Diabetic Foot Ulcers
2023-09-19 08:03
U
U:BSEM
News Release
200
BioStem Technologies Initiates Nationwide Launch of AmnioWrap2(TM) with Venture Medical
2023-09-18 08:33
U
U:BSEM
News Release
200
BioStem Technologies Engages PCG Advisory for Strategic Investor Relations
2023-09-11 08:00
U
U:BSEM
News Release
200
NovaBay Pharmaceuticals Announces Agreement with BioStem Technologies to Commercialize Amniotic Tissue Allograft as Avenova ‚ ® Allograft
2023-09-06 12:00
U
U:BSEM
News Release
200
BioStem Awarded a Spot on ECAT, DAPA, and FSS Contract Vehicles Through SDVOSB, Lovell